We offer an innovative, multidisciplinary environment in which you will work as part of the NextGen consortium. Within the consortium, our group aims to identify which genes and biological pathways are involved in cardiovascular disease, with a focus on GWAS, polygenic risk scores (PRS) and drug metabolism (pharmacogenetics). You will work with large (array) genotyped, WGS, and WES datasets utilizing data of hundreds of thousands of samples. We have a combination of deep-phenotyped in-house data and large external cohorts, such as UK Biobank and All of Us. You will work closely with bioinformaticians from the clinical genetics department. We are currently a compact, yet growing group, and as we continue to expand, we are looking for a candidate interested in a long-term role. This also means that there will be flexibility in your responsibilities, tailored to our shared short-term and long-term goals.